Cancer-Hit Health Insurance Employee Denied Work from Home, Ultimately Fired

A US-based health insurance company employee, suffering from stage 2 lymphoma, was denied the possibility of working from home despite a doctor's note advocating for remote work to minimize infection risk during chemotherapy. The employee's position was deemed "impossible to perform remotely" by the HR department, while the entire department had worked from home during the COVID-19 pandemic. The company's response to the employee's plight drew outrage from fellow Redditors, who expressed sympathy for the cancer-stricken employee and criticized the company's behavior as inhumane. The employee has since filed a lawsuit under the Americans with Disabilities Act (ADA), citing the company's alleged violations of the law.

Key Takeaways:

• The employee worked as a claims analyst for over three years at HealthPlus Insurance before being diagnosed with stage 2 lymphoma.
• Despite proper documentation, including a doctor's note, the company denied the possibility of remote work, citing that the role was "impossible to perform remotely."
• The company allowed the employee to take unpaid medical leave on days scheduled for chemotherapy, but required them to be in the office on other days, violating the ADA.
• The employee's productivity and performance suffered due to ongoing chemotherapy, and they were eventually put on a "performance improvement plan" and fired for "failing to meet productivity standards."
• The employee has filed a lawsuit under the ADA, citing the company's alleged lies about being exempt from ADA requirements due to having fewer than 50 employees.
• The company allegedly had 53 employees, making it subject to ADA requirements.

Statistics:

• The employee was diagnosed with stage 2 lymphoma last fall.
• The company had 53 employees, making it subject to ADA requirements.
• The employee worked from home during chemotherapy sessions on unpaid medical leave.
• The employee's productivity and performance suffered due to ongoing cancer treatment, leading to their eventual termination.

Sources:

• None cited in the original text.